End of recruitment

The patient enrollment for the EAST-AFNET 4 trial is completed. Many thanks to all study centers and recruiters for their excellent support.

2.789 patients have been randomized in 11 countries as of December 31st 2016. A big thanks to all involved. 168 sites contributed to this great achievement.

After the end of recruitment, EAST will be in its Follow-Up Phase until approximately summer 2019. Since EAST is an event-driven study the last patient that has been enrolled has to be followed up for 2.5 years in order to collect the required primary events.

This will ensure a high quality study data and allow for a significant final analysis.